The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ContraFect Corporation(NASDAQ:CFRX)
ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an i...
Website: http://www.contrafect.com
Founded: 2008
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
ContraFect Op Cashflow Per Share ttm
ContraFect Free Cashflow Per Share ttm
ContraFect Cash Per Share ttm
ContraFect P/S ratio ttm
ContraFect (GAAP) P/E ratio ttm
ContraFect P/B ratio ttm
No extra charts and metrics for this ticker.
